卡介苗多糖核酸治疗支气管哮喘临床观察  

The clinic observation of polysaccharide nucleicacid of bacille calmette-guerin injection on bronchus asthmatic patients

作　　者：李长春[1] 

机构地区：[1]东莞市桥头医院急诊科,广东省东莞523538

出　　处：《中国基层医药》2006年第7期1068-1069,共2页Chinese Journal of Primary Medicine and Pharmacy

摘　　要：目的探讨卡介苗多糖核酸对支气管哮喘临床症状和肺通气功能的影响。方法60例支气管哮喘患者随机分为两组,治疗组在对照组的治疗基础上加用卡介苗多糖核酸,治疗前和治疗后6个月分别检测肺功能。结果治疗组和对照组临床症状和肺功能均明显改善,治疗组有效率为96·7%,对照组有效率为80%(P<0·05)。结论卡介苗多糖核酸可以减轻气道炎症,改善肺通气功能,对防治支气管哮喘有较好的效果。Objective To observe the influence on clinic symptom and pulmonary function in asthmatic patients treated with polysaccharide nucleicacid of ealmette-guerin（BCG-PSN） injection in asthmatic patients. Methods 30 cases（ treatment group） with additional BCG-PSN injection and 30 eases（control group） with only normal treatment were studied in contrast. They were observed in pulmonary function and clinic symptom before and after treatment. Results Symptom and pulmonary function improved in both groups. The validity rate in treatment group was 96.7 %, and the control group was 80 %. Conclusion BCG-PSN could alleviate the inflammation of bronchus and excellent effects of BCG-PSN injection in treatment on clinic symptom and pulmonary function of asthmatic patients were found.

关 键 词：支气管哮喘 肺功能 卡介苗多糖核酸 

分 类 号：R562.25[医药卫生—呼吸系统] R22[医药卫生—内科学]